AbbVie Total Long Term Liabilities 2010-2024 | ABBV

AbbVie total long term liabilities for the quarter ending June 30, 2024 were $93.201B, a 3.29% increase year-over-year.

  • AbbVie total long term liabilities for 2023 were $86.473B, a 5.99% decline from 2022.
  • AbbVie total long term liabilities for 2022 were $91.98B, a 4.09% decline from 2021.
  • AbbVie total long term liabilities for 2021 were $95.899B, a 11.86% decline from 2020.

AbbVie Total Long Term Liabilities 2010-2024 | ABBV

  • AbbVie total long term liabilities for 2023 were $86.473B, a 5.99% decline from 2022.
  • AbbVie total long term liabilities for 2022 were $91.98B, a 4.09% decline from 2021.
  • AbbVie total long term liabilities for 2021 were $95.899B, a 11.86% decline from 2020.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$495.1B
Johnson & Johnson (JNJ)$450.1B
Novo Nordisk (NVO)$424.5B
Merck (MRK)$270B
AstraZeneca (AZN)$218.5B
Novartis AG (NVS)$218.4B
Pfizer (PFE)$201.2B
Sanofi (SNY)$133B
Innoviva (INVA)$953M